CAS: 19721-56-3; Picromycin

该化合物是一种以14人组成的乳腺环结构为显著特征的由静脉切除细胞Venezuelae 生产出来的大型抗生素.它展示了广泛的抗生素抗生素活动,特别是针对抗乳腺细菌的抗生素活动,通过与50S 脊髓膜炎子细胞结合,抑制蛋白质合成. Pikromycin 作为其他具有临床重要性的巨粒子的生物合成前体,因此对抗生素发展和合成生物学的研究很有价值. 它相对简单的结构促进了对大型硅生物合成和工程的研究. 化合物还被用于调查抗生素机制并优化衍生物化合物以提高功效. Pikromycin在早期抗生素发现中的作用强调了其在微生物和药物研究中的重要性.

结构式图片

上下游产品

那波霉素 Narbomycin 6036-25-5
(E)-(3R,5R,6S,7S,9R,13S,14R)-14-Ethyl-13-Hydroxy-6-(4-Methoxybenzyloxy)-3,5,7,9,13-Pentamethyloxacyclotetradec-11-Ene-2,4,10-Trione 1353285-79-6
(E)-(3R,4S,5S,6S,7S,9R,13S,14R)-14-Ethyl-4,13-Dihydroxy-6-(4-Methoxybenzyloxy)-3,5,7,9,13-Pentamethyloxacyclotetradec-11-Ene-2,10-Dione 1353285-77-4
(E)-(3R,4S,5R,6S,7S,9R,13S,14R)-4-(Tert-Butyldimethylsilyloxy)-14-Ethyl-13-Hydroxy-6-(4-Methoxybenzyloxy)-3,5,7,9,13-Pentamethyloxacyclotetradec-11-Ene-2,10-Dione 1353285-75-2

合成工艺路线路线简述

  • 合成目标产物 Picromycin 主要起始原料 Oxacyclotetradec-11-Ene-2,4,10-Trione, 6-[[2-O-Acetyl-3,4,6-Trideoxy-3-(Dimethylamino)-β-D-Xylo-Hexopyranosyl]Oxy]-14-Ethyl-13-Hydroxy-3,5,7,9,13-Pentamethyl-, (3R,5R,6S,7S,9R,11E,13S,14R)-
  • (文献来源)合成步骤主要原料 Oxacyclotetradec-11-Ene-2,4,10-Trione, 6-[[2-O-Acetyl-3,4,6-Trideoxy-3-(Dimethylamino)-β-D-Xylo-Hexopyranosyl]Oxy]-14-Ethyl-13-Hydroxy-3,5,7,9,13-Pentamethyl-, (3R,5R,6S,7S,9R,11E,13S,14R)-
📜[(2S,3R,4S,6R)-4-(Dimethylamino)-2-[[(3R,5R,6S,7S,9R,11E,13S,14R)-14-Ethyl-13-Hydroxy-3,5,7,9,13-Pentamethyl-2,4,10-Trioxo-1-Oxacyclotetradec-11-En-6-Yl]Oxy]-6-Methyloxan-3-Yl] Acetate置于水,三乙胺体系中,用 甲醇 用作溶剂,化学反应 3.0H,以91%的收率获得白丝菌素
参考文献:吡咯霉素的全合成
标题:吡咯霉素的全合成
摘要:第一个分离出的大环内酯类抗生素吡咯霉素(6)的总合成得以实现.将目标大环内酯逆合成合成为两部分,吡克洛内酯(6A)(糖苷配基)和d-去糖胺.糖苷配基是使用关键反应合成的,例如不对称的醛醇缩合反应,山口酯化反应和闭环易位反应.在路易斯酸性条件下,将糖苷配基与d-去糖胺的三氯乙亚胺衍生物成功偶联,得到吡咯霉素.Narbomycin(5)也从narbonolide(合成5A)相同的条件下.
Doi:10.1021/jo201158Q

海关参考信息

专利信息


专利号:US-2004018598-A1
优先权日:2000-05-30
标题 :Bio-intermediates for use in the chemical synthesis of polyketides
发明人:SANTI DANIEL; ASHLEY GARY; MYLES DAVID C
摘要:The present invention relates to compounds made by a subset of modules from one or more polyketide synthase (“PKSâ€?) genes that are used as starting material in the chemical synthesis of novel molecules, particularly naturally occurring polyketides or derivatives thereof. The biologically derived intermediates (“bio-intermediatesâ€?) generally represent particularly difficult compounds to synthesize using traditional chemical approaches due to one or more stereocenters. In one aspect of the invention, an intermediate in the synthesis of epothilone is provided that feeds into the synthetic protocol of Danishefsky and co-workers. In another aspect of the invention, intermediates in the synthesis of discodermolide are provided that feed into the synthetic protocol of Smith and co-workers. By taking advantage of the inherent stereochemical specificity of biological processes, the syntheses of key intermediates and thus the overall syntheses of compounds like epothilone and discodermolide are greaty simplified.

专利号:US-11186835-B2
优先权日:2018-01-11
标题 :Artificial ribosomes for fully programmable synthesis of nonribosomal peptides
发明人:GREEN ALEXANDER A
权利人:UNIV ARIZONA STATE
摘要:Provided herein, in some embodiments, are artificial ribosomes that synthesize nonribosomal peptides, polyketides, and fatty acids with full control over peptide sequence. Also provided herein are methods for programmed synthesis of nonribosomal peptides, polyketides, and fatty acids. In particular, provided herein are methods for scalable synthesis of a wide range of antibacterial, antifungal, antiviral, and anticancer compounds.

专利号:US-2008044860-A1
优先权日:2003-11-28
标题 :Polyketides and Their Synthesis
发明人:GAISSER SABINE; HAYDOCK STEPHEN FREDERICK; LEADLAY PETER FRANCIS; MCARTHUR HAMISH ALASTAIR IRVIN
权利人:GAISSER SABINE; HAYDOCK STEPHEN FREDERICK; LEADLAY PETER FRANCIS; MCARTHUR HAMISH ALASTAIR IRVIN
摘要:Macrolides particularly erythromycins and azithromycins, having O-mycaminosyl or O-angolosaminyl groups, particularly at the 5 -position, are produced using a gene cassette comprising a combination of genes which, in an appropriate strain background, are able to direct the synthesis of mycaminose or angolosamine and to direct its subsequent transfer to an aglycone or pseudoaglycone. Synthetic genes may comprise one or more of angMIII, angMI, angB, angAI, angAII, angorf14, angorf4, tylMIII, tylMI, tylB, tylAI, tylAII, eryCVI, spnO, eryBVI, eryK, tyl Ia and ery G. Glycosyltransfer genes may comprise one or more of eryCIII, tylMII, angMII, desVII, eryBV, spnP and midI.

专利号:US-2002192767-A1
优先权日:1999-10-13
标题 :Biosynthesis of polyketide synthase substrates
发明人:KHOSLA CHAITAN; PFEIFER BLAINE
摘要:The use of enzymes which catalyze the production of starter and extender units for polyketides is described. In addition, modified loading modules are described, which can accept a variety of starting units such as substituted benzoates, and which can be used to generate substituted derivatives of natural products. These enzymes may be used to enhance the yield of polyketides that are natively produced or polyketides that are rationally designed. By using these techniques, the synthesis of a complete polyketide has been achieved in E. coli . Production can be enhanced in microbial organisms of polyketides and other secondary metabolites by delaying production until after exponential phase and by maintaining relatively constant nutrient levels in the medium. In addition, polyketide production can be enhanced by providing an expression system for a thioesterase II. Thus, by modifying the host organism and changing the culture conditions, synthesis of a secondary metabolite can be enhanced. The present invention also results in a host organism with desirable characteristics to be used in the production of such polyketides and to assess the results of gene shuffling.

专利号:WO-02068613-A1
优先权日:2001-02-28
标题 :Biosynthesis of polyketide synthase substrates
发明人:KHOSLA CHAITAN; PFEIFER BLAINE
权利人:UNIV LELAND STANFORD JUNIOR; KHOSLA CHAITAN; PFEIFER BLAINE
摘要:The use of enzymes which catalyze the production of starter and extender units for polyketides is described. In addition, modified loading modules are described, which can accept a variety of starting units such as substituted benzoates, and which can be used to generate substituted derivatives of natural products. These enzymes may be used to enhance the yield of polyketides that are natively produced or polyketides that are rationally designed. By using these techniques, the synthesis of a complete polyketide has been achieved in E. coli. Production can be enhanced in microbial organisms of polyketides and other secondary metabolites by delaying production until after exponential phase and by maintaining relatively constant nutrient levels in the medium. In addition, polyketide production can be enhanced by providing an expression system for a thioesterase II. Thus, by modifying the host organism and changing the culture conditions, synthesis of a secondary metabolite can be enhanced. The present invention also results in a host organism with desirable characteristics to be used in the production of such polyketides and to assess the results of gene shuffling.

专利号:US-7595156-B2
优先权日:2003-10-23
标 题:Genes for synthesis of FR-008 polyketides
发明人:LEE SANG YUP; DENG ZIXIN; CHEN SHI; JEONG KI JUN; ZHOU XIUFEN
权利人:KOREA ADVANCED INST SCI & TECH
摘要:The present invention relates to the base sequence of whole genes involved in the biosynthesis of FR-008 polyketides derived from Streptomyces sp. FR-008. This base sequence comprises genes coding for ketosynthase (KS), acyl transferase (AT), acyl carrier protein (ACP), ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, sugar synthetic protein, FAD-dependent monooxygenase, 4-amino-4-deoxychorismate (ADC) synthase and ADC lyase. The gene base sequence according to the present invention can be used to increase the productivity of the existing FR-008 polyketides or produce new FR-008 polyketides, through modification of its parts.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Almutairi MM, Svetlov MS, Hansen DA, Khabibullina NF, Klepacki D, Kang HY, Sherman DH, Vázquez-Laslop N, Polikanov YS, Mankin AS. Co-produced natural ketolides methymycin and pikromycin inhibit bacterial growth by preventing synthesis of a limited number of proteins. Nucleic Acids Res. 2017 Sep 19;45(16):9573-9582. doi: 10.1093/nar/gkx673.
2: Goldberg VE, Polyakova TY, Popova NO, Vysotskaya VV, Simolina EI, Belevich YV, Tuzikova TP, Goldberg AV, Zhdanov VV, Miroshnichenko LA, Udut EV, Simanina EV, Dygai AM, Zyuz'kov GN. Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma. Bull Exp Biol Med. 2017 Aug;163(4):469-474. doi: 10.1007/s10517-017-3830-y. Epub 2017 Aug 29. doi: 10.1021/jacs.7b06432. Epub 2017 Sep 19.
4: Koch AA, Hansen DA, Shende VV, Furan LR, Houk KN, Jiménez-Osés G, Sherman DH. A Single Active Site Mutation in the Pikromycin Thioesterase Generates a More Effective Macrocyclization Catalyst. J Am Chem Soc. 2017 Sep 27;139(38):13456-13465. doi: 10.1021/jacs.7b06436. Epub 2017 Sep 19.

合成参考文献


摘要:Antibiotics: Origin, Nature, and Properties, Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978, 1(101), 1978
摘要:Index of Antibiotics from Actinomycetes, Umezawa, H. et al., eds., Tokyo, Univ. of Tokyo Press, 1967, -(114), 1967
参考文献:10.1016/s1074-5521(99)80087-8
摘要:Tang L, Fu H, Betlach MC, McDaniel R. Elucidating the mechanism of chain termination switching in the picromycin/methymycin polyketide synthase. Chem Biol. 1999 Aug;6(8):553–8. doi: 10.1016/s1074-5521(99)80087-8.
参考文献:10.1021/ja049967j
摘要:Borisova SA, Zhao L, Melançon III CE, Kao CL, Liu HW. Characterization of the glycosyltransferase activity of desVII: analysis of and implications for the biosynthesis of macrolide antibiotics. J Am Chem Soc. 2004 Jun 02;126(21):6534–5. doi: 10.1021/ja049967j.
参考文献:10.1007/s00253-003-1535-9
摘要:Nedal A, Zotchev SB. Biosynthesis of deoxyaminosugars in antibiotic-producing bacteria. Applied Microbiology and Biotechnology. 2004 Mar 01;64(1):7–15. doi: 10.1007/s00253-003-1535-9.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知